Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
April 10, 2025 16:05 ET | Source: Protara Therapeutics NEW YORK, April…
NCCN 2025 Annual Conference Illustrates the Critical Impact of Cancer Research on Improving Lives
The National Comprehensive Cancer Network celebrated its 30th anniversary with a series…
IOC Session celebrates the achievements of Olympic Agenda
19 March 2025 - IOC Members meeting at the 144th Session in Greece, today celebrated…
Alumis Announces Late-Breaker Psoriasis Presentation of 52-week Phase 2 OLE Data for ESK-001 at 2025 American Academy of Dermatology Annual Meeting and Accelerated Topline Phase 3 Data Readout
– Late-breaking oral presentation to highlight 52-week data of ESK-001 in a…
CORRECTING and REPLACING Agenus BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting
LEXINGTON, Mass.--(BUSINESS WIRE)--Proffered Papers, Session 2, Session Date and Time of release…
Lantheus to Present at Upcoming Investor Conferences
February 21, 2025 08:30 ET | Source: Lantheus Holdings, Inc. BEDFORD, Mass.,…
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
February 14, 2025 16:05 ET | Source: Dyne Therapeutics, Inc. - Data…
Keypoint Intelligence’s Peter Mayhew to Share Industry Expertise at Remanexpo Academy During Ambiente 2025
FAIRFIELD, N.J., Jan. 29, 2025 /PRNewswire/ -- Peter Mayhew, Principal Analyst at Keypoint…
Information for the media media opportunity at Olympic House on 30 January 2025
10 December 2024 - As previously announced, the International Olympic Committee (IOC) membership will…
IOC Ethics Commission draws lots to determine order of presidential candidate presentations
26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing…